Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Metastatic Castration-resistant Prostate Cancer × Radionuclide Imaging × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Nose Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Liver Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Cancer Diagnosis 1 Breast Neoplasms 1

Interventions

olaparib 2 enzalutamide 2 Prednisone 2 Abiraterone Acetate 2 radium Ra 223 dichloride 1 poly ICLC 1 fluciclovine F-18 1 bempegaldesleukin 1 afuresertib 1 Radiosurgery 1 Radionuclide Imaging 1 Nivolumab 1 Clinical Trials, Phase I as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04000776 2023-08-28

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Université de Sherbrooke

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡